RHJA
ANGO icon

Rice Hall James & Associates’s AngioDynamics ANGO Stock Holding History

Rice Hall James & Associates’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-306,635
Closed -$2.39M – 251
2024
Q3 		$2.39M Sell
306,635
-2,885
-0.9% -$20.8K 0.13% 161
2024
Q2 		$1.87M Sell
309,520
-20,376
-6% -$126K 0.11% 167
2024
Q1 		$1.94M Sell
329,896
-987
-0.3% -$5.86K 0.11% 175
2023
Q4 		$2.59M Buy
330,883
+73,131
+28% +$507K 0.15% 143
2023
Q3 		$1.88M Buy
257,752
+89,683
+53% +$746K 0.12% 175
2023
Q2 		$1.75M Buy
+168,069
New +$1.62M 0.1% 186
2015
Q4 		– Sell
-152,667
Closed -$2.01M – 301
2015
Q3 		$2.01M Buy
152,667
+2,000
+1% +$30.2K 0.13% 167
2015
Q2 		$2.47M Sell
150,667
-690
-0.5% -$11.5K 0.14% 159
2015
Q1 		$2.69M Sell
151,357
-36,006
-19% -$669K 0.16% 150
2014
Q4 		$3.56M Sell
187,363
-1,362
-0.7% -$23.1K 0.22% 118
2014
Q3 		$2.59M Sell
188,725
-2,693
-1% -$38.4K 0.18% 154
2014
Q2 		$3.13M Sell
191,418
-1,486
-0.8% -$21.5K 0.21% 112
2014
Q1 		$3.04M Sell
192,904
-5,137
-3% -$83.7K 0.22% 122
2013
Q4 		$3.4M Buy
+198,041
New +$3.05M 0.25% 103

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rice Hall James & Associates's ANGO Position: Q4 2024 in Review

Rice Hall James & Associates sold out of AngioDynamics (ANGO) in Q4 2024, closing a stake of 306,635 shares — an estimated $2.39M sold.

Rice Hall James & Associates first reported a position in ANGO in Q4 2013 and held it in 14 quarters. The position peaked at $3.56M in Q4 2014. 135 funds tracked by Wall St. Rank hold ANGO as of Q4 2024.

  • Rice Hall James & Associates reported no remaining AngioDynamics position as of Q4 2024 after selling out during the quarter.
  • Rice Hall James & Associates sold 306,635 AngioDynamics shares in Q4 2024, an estimated $2.39M.
  • Rice Hall James & Associates first reported a position in AngioDynamics in Q4 2013 and held it in 14 quarters.
  • Rice Hall James & Associates's AngioDynamics position peaked at $3.56M in Q4 2014.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2024.

Based on Rice Hall James & Associates's 13F filing for Q4 2024, filed 31 Jan 2025.